VectivBio Holding AG

NASDAQ: VECT · Real-Time Price · USD
16.87
0.02 (0.12%)
At close: Jul 07, 2023, 9:59 PM

VectivBio Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-93.73M -87.01M
Depreciation & Amortization
239K 303K
Stock-Based Compensation
16.77M 24.9M
Other Working Capital
16.28M 1.77M
Other Non-Cash Items
10.97M -11.45M
Deferred Income Tax
n/a -76K
Change in Working Capital
9.5M 1.19M
Operating Cash Flow
-56.26M -72.14M
Capital Expenditures
-74K -57K
Cash Acquisitions
n/a -1.2M
Purchase of Investments
n/a n/a
Sales Maturities Of Investments
n/a n/a
Other Investing Acitivies
n/a -5.42M
Investing Cash Flow
-74K -6.67M
Debt Repayment
n/a n/a
Common Stock Repurchased
-5K n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
175.06M 141.33M
Financial Cash Flow
175.06M 141.33M
Net Cash Flow
118.71M 62.53M
Free Cash Flow
-56.33M -72.2M